Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa

被引:95
作者
Fox, Matthew P. [1 ,2 ,3 ]
Brennan, Alana [2 ]
Maskew, Mhairi [4 ,5 ]
MacPhail, Patrick [4 ,5 ]
Sanne, Ian [4 ,5 ]
机构
[1] Boston Univ, Ctr Global Hlth & Dev, Crosstown Ctr, Boston, MA 02118 USA
[2] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[4] Right Care, Johannesburg, South Africa
[5] Univ Witwatersrand, Dept Med, Clin HIV Res Unit, ZA-2001 Johannesburg, South Africa
关键词
human immunodeficiency virus; antiretroviral therapy; mortality; loss to follow up; risk factors; South Africa; sub-Saharan Africa; ACTIVE ANTIRETROVIRAL THERAPY; RESOURCE-POOR SETTINGS; SURVIVAL; OUTCOMES; METAANALYSIS; EFFICACY; AIDS;
D O I
10.1111/j.1365-3156.2010.02473.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To estimate the rates of mortality in patients lost to follow-up (LTFU) from a large urban public sector HIV clinic in South Africa. METHODS We compared vital status using the clinic's database to vital status verified against the Vital Registration system at the South African Department of Home Affairs. We compared rates of mortality before and after updating mortality data. Predictors of mortality were estimated using Kaplan-Meier curves and proportional hazard regression. RESULTS Of the 7097 total patients who initiated highly active antiretroviral therapy at Themba Lethu Clinic by October 1st, 2008 and had an ID number, 6205 were included. 2453 patients (21%) were LTFU, of whom 1037 (42.3%) could be included in the analysis. After matching to the vital registration system, mortality more than doubled from 4.2% (258/6205) to 10.9% (676/6205). Overall 37% of those LTFU died by life-table analysis the probability of survival amongst those LTFU was 69% (95% CI: 66-72%), 64% (95% CI: 61-67%) and 59% (95% CI: 55-62%) by years 1, 2 and 3 since being lost, respectively. Those at highest risk of death after being lost were patients with a history of tuberculosis, CD4 count < 100 cells/mu l, BMI < 17.5, haemoglobin < 10 and on < 6 months of treatment. CONCLUSION Mortality was substantially underestimated among patients lost from a South African HIV treatment programme despite limited active tracing. Linking to vital registration systems can provide more accurate assessments of programme effectiveness and target lost patients most at risk for mortality.
引用
收藏
页码:405 / 413
页数:9
相关论文
共 25 条
[1]  
[Anonymous], 5 IAS C HIV PATH TRE
[2]  
[Anonymous], 2004, NAT ANT TREATM GUID
[3]  
[Anonymous], 2005, MORT CAUS DEATH S AF
[4]   Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts [J].
Bisson, Gregory P. ;
Gaolathe, Tendani ;
Gross, Robert ;
Rollins, Caitlin ;
Bellamy, Scarlett ;
Mogorosi, Mpho ;
Avalos, Ava ;
Friedman, Harvey ;
Dickinson, Diana ;
Frank, Ian ;
Ndwapi, Ndwapi .
PLOS ONE, 2008, 3 (03)
[5]  
Bodri M, 2006, ANTIVIR THER, V11, P63
[6]   Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis [J].
Brinkhof, Martin W. G. ;
Pujades-Rodriguez, Mar ;
Egger, Matthias .
PLOS ONE, 2009, 4 (06)
[7]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[8]  
Dorrington Rob., 2001, The impact of HIV / AIDS on adult mortality in South Africa
[9]   Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies [J].
Egger, M ;
May, M ;
Chêne, G ;
Phillips, AN ;
Ledergerber, B ;
Dabis, F ;
Costagliola, D ;
Monforte, AD ;
de Wolf, F ;
Reiss, P ;
Lundgren, JD ;
Justice, AC ;
Staszewski, S ;
Leport, C ;
Hogg, RS ;
Sabin, CA ;
Gill, MJ ;
Salzberger, B ;
Sterne, JAC .
LANCET, 2002, 360 (9327) :119-129
[10]   Effectiveness of antiretroviral treatment in a South African program - A cohort study [J].
Fairall, Lara R. ;
Bachmann, Max O. ;
Louwagie, Goedele M. C. ;
van Vuuren, Cloete ;
Chikobvu, Perpetual ;
Steyn, Dewald ;
Staniland, Gillian H. ;
Timmerman, Venessa ;
Msimanga, Mpumelelo ;
Seebregts, Chris J. ;
Boulle, Andrew ;
Nhiwatiwa, Ralph ;
Bateman, Eric D. ;
Zwarenstein, Merrick F. ;
Chapman, Ronald D. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) :86-93